A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials